Anti-Calpain Small Subunit 2 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting the regulatory small subunit of calpain proteases, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q96L46
Size
100ug
Cat. #
RP1CalpainS2

In stock

SKU
RP-CalpainS2

Options

As low as: $130.00

Target Overview

Calpain small subunit 2 (CAPNS2, UniProt Q96L46), also known as CSS2, is the 248-amino acid regulatory component of calcium-dependent cysteine proteases. The calpain system consists of a catalytic large subunit paired with this small subunit, which functions as a tissue-specific chaperone facilitating proper folding and conformational activation of the proteolytic domain. CAPNS2 localizes to the cytoplasm and is essential for the activity of calcium-regulated non-lysosomal thiol-proteases that catalyze limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Unlike lysosomal cathepsins, calpains perform selective cleavage rather than complete degradation, making them central regulators of cellular architecture, motility, and apoptotic signaling. The small subunit contains EF-hand calcium-binding domains (Domain V) that contribute to calcium sensitivity and enzyme stability. Researchers study CAPNS2 to understand calcium-dependent proteolytic regulation in normal physiology and pathological states including neurodegeneration, muscular dystrophy, and cancer metastasis where aberrant calpain activity disrupts cytoskeletal integrity and cell survival pathways.

Background

The calpain protease family represents a conserved group of calcium-activated enzymes that perform limited proteolysis distinct from the complete degradation carried out by proteasomes or lysosomes. CAPNS2 serves as the obligate regulatory partner for multiple calpain catalytic subunits, and its expression pattern can determine tissue-specific protease activity. The small subunit stabilizes the large catalytic subunit in the calcium-free state and undergoes conformational changes upon calcium binding that permit substrate access to the active site. This regulatory mechanism allows cells to couple proteolytic events directly to calcium signaling, linking membrane depolarization, receptor activation, or stress responses to cytoskeletal remodeling and protein turnover. Calpain substrates include structural proteins such as spectrin, talin, and focal adhesion kinase, as well as signaling molecules including protein kinase C isoforms and transcription factors. Dysregulated calpain activity has been implicated in calcium-dependent cell death following ischemic injury, excitotoxicity in neurons, and the progression of muscular dystrophies where calcium homeostasis is disrupted. The balance between calpain proteolysis and its endogenous inhibitor calpastatin determines the extent of substrate cleavage under physiological versus pathological calcium elevations. Recent proteomic studies continue to identify novel calpain substrates across diverse cellular processes. For example, phosphoproteomic mapping of kinase networks in cancer has revealed extensive crosstalk between post-translational modifications that may include calpain-mediated cleavage events, as demonstrated in studies examining DNA damage response pathways and their dysregulation in tumor progression (Kashipatna SS et al, 2026). Understanding the substrate specificity conferred by different small subunit isoforms remains an active area of investigation, with implications for therapeutic strategies targeting calcium-dependent proteolysis in disease contexts.

References

  1. Kashipatna SS et al (2026) Site-Specific Phosphoproteomics Uncovers Potential Regulatory Networks of NEK4 in DNA Damage Response and Cancer Progression. OMICS. PubMed · DOI

Additional Specifications

Gene Symbol CPNS2
UniProt ID Q96L46
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Aminoterminal end Domain-V, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-50.
Immunogen (Carboxyterminal end Domain-V, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 198-248.
Immunogen (Carboxyterminal end Domain-VI, Small subunit)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 198-248.
Alternate Names CAPNS2, Calpain small subunit 2, CSS2, Calcium-dependent protease small subunit 2, Calpain regulatory subunit

Frequently Asked Questions

What molecular weight band should I expect for CAPNS2 on Western blot?

CAPNS2 migrates at approximately 28-30 kDa on Western blot, corresponding to the 248-amino acid full-length protein. You may observe a doublet or slight molecular weight variation depending on post-translational modifications or proteolytic processing. The small subunit remains relatively stable compared to the catalytic large subunits, so you should see a single predominant band in most lysates. If you observe higher molecular weight species, consider that CAPNS2 forms stable heterodimers with large calpain subunits, though under reducing SDS-PAGE conditions these complexes typically dissociate.

What is the optimal starting dilution for Western blot with this Calpain-S2 antibody?

Begin with a 1:1000 dilution in blocking buffer containing 5% non-fat milk or BSA in TBST. This rabbit polyclonal typically produces clean signal at this dilution with 20-50 µg total protein per lane. If your signal is weak, particularly in samples with low CAPNS2 expression, you can increase antibody concentration to 1:500. Overnight incubation at 4°C often improves sensitivity compared to one-hour room temperature incubations. Always include a lysate known to express CAPNS2 as a positive control to confirm antibody performance in your hands.

Does this antibody distinguish between CAPNS1 and CAPNS2 isoforms?

The two small subunit isoforms, CAPNS1 and CAPNS2, share approximately 60% sequence identity and similar molecular weights, making isoform-specific detection challenging. This antibody is raised against CAPNS2, but you should verify specificity for your application through siRNA knockdown or CAPNS2-null cell lines if distinguishing between isoforms is critical to your experiment. CAPNS1 is ubiquitously expressed while CAPNS2 shows more restricted tissue distribution, so tissue context may provide some functional inference. For rigorous isoform discrimination, consider parallel knockdown experiments as biological controls.

Will this antibody work in mouse or rat samples?

This antibody has been validated for human CAPNS2. Cross-reactivity with mouse and rat is predicted based on high sequence homology across mammalian species—human and mouse CAPNS2 share approximately 90% identity at the amino acid level. However, we have not formally validated reactivity in rodent tissues. If you are working with mouse or rat lysates, we recommend testing the 1:1000 dilution initially and including a positive control human lysate on the same blot. Researchers in our experience have reported successful detection in rodent samples, but optimal dilution may require adjustment.

What positive control tissues or cell lines express high levels of CAPNS2?

CAPNS2 is broadly expressed across human tissues, with relatively higher abundance in skeletal muscle, heart, and brain based on transcriptomic data. For a convenient positive control, HeLa or HEK293 lysates typically show detectable CAPNS2 expression at standard loading amounts. If you are studying tissue-specific regulation, consider that CAPNS2 expression may be inducible under certain conditions such as differentiation or calcium flux. Preparing lysates from proliferating cultured cells generally provides consistent baseline expression suitable for validating antibody performance before moving to experimental samples.

Can I use this antibody for immunofluorescence or immunohistochemistry?

Triple Point Biologics antibodies are routinely validated for Western blot applications. This rabbit polyclonal should be compatible with both immunofluorescence and immunohistochemistry, though we have specifically validated Western blot performance for this Calpain-S2 antibody. For IHC or IF, start with a 1:100 to 1:200 dilution and optimize based on your fixation method and tissue type. Antigen retrieval may be necessary for formalin-fixed paraffin-embedded tissues—citrate buffer pH 6.0 is a standard starting point. Expect cytoplasmic staining consistent with CAPNS2 localization.

How should I store this antibody and what is the expected stability?

Store the antibody at -20°C in the provided glycerol-containing buffer. Avoid repeated freeze-thaw cycles, which can reduce titer and increase background. For routine use, consider preparing small aliquots immediately upon receipt. The antibody remains stable for at least 12 months when stored properly at -20°C. If you use the antibody frequently, a working aliquot can be kept at 4°C for up to one month with 0.02% sodium azide as preservative. Do not store diluted antibody in blocking buffer for more than one week, as carrier proteins can degrade and affect performance.

What sample preparation considerations are important for detecting CAPNS2?

Use standard RIPA or NP-40 lysis buffers with protease inhibitors—CAPNS2 is a cytoplasmic protein and extracts efficiently under non-denaturing conditions. Because the calpain system is calcium-dependent, include EDTA or EGTA in your lysis buffer to prevent artifactual proteolysis during sample preparation. CAPNS2 itself is relatively stable, but active calpains in the lysate can cleave other substrates if calcium is present. Boil samples in SDS loading buffer immediately after quantification. For cultured cells, 20-50 µg total protein per lane is typically sufficient. Fresh lysates generally give better results than samples subjected to multiple freeze-thaw cycles.

Western blot validation for RP-CalpainS2 — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Calpain-S2: Aminoterminal end Domain-V, Small subunit — WB validation
WB · Panel 1 Calpain-S2: Aminoterminal end Domain-V, Small subunit
Calpain-S2: Carboxyterminal end Domain-V, Small subunit — WB validation
WB · Panel 2 Calpain-S2: Carboxyterminal end Domain-V, Small subunit

Custom validation studies available on request — contact us.

Also known as:

  • CAPNS2
  • Calpain small subunit 2
  • CSS2
  • Calcium-dependent protease small subunit 2
  • Calpain regulatory subunit
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →